Patents by Inventor Robert W. Brocia

Robert W. Brocia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR ISOLATION OF MAO INHIBITORS FROM TEQUILA OR OTHER DISTILLED AGAVE FERMENTATION PRODUCTS
    Publication number: 20240091297
    Abstract: Improved compositions of reversible monoamine oxidase inhibitors are obtained by improved methods of alcohol removal from distillates of fermented agave extracts.
    Type: Application
    Filed: April 27, 2023
    Publication date: March 21, 2024
    Applicant: Roar Holding LLC
    Inventor: Robert W. BROCIA
  • Methods to improve beverage quality
    Patent number: 11879115
    Abstract: Agave derived beverages with improved quality contain enhanced ratios of MAO B to MAO A inhibitors or enhanced concentration of inhibitor of MAO B.
    Type: Grant
    Filed: November 26, 2019
    Date of Patent: January 23, 2024
    Assignee: Roar Holding LLC
    Inventor: Robert W. Brocia
  • ENERGY DRINKS AND OTHER NUTRITIONAL AIDS DERIVED FROM AGAVE-BASED SPIRITS
    Publication number: 20220047531
    Abstract: Compositions containing monoamine oxidase inhibitors prepared by removal of alcohol from agave-derived beverages are disclosed.
    Type: Application
    Filed: October 29, 2021
    Publication date: February 17, 2022
    Applicant: Roar Holding LLC
    Inventor: Robert W. BROCIA
  • Energy drinks and other nutritional aids derived from agave-based spirits
    Patent number: 11160774
    Abstract: Compositions containing monoamine oxidase inhibitors prepared by removal of alcohol from agave-derived beverages are disclosed.
    Type: Grant
    Filed: February 1, 2019
    Date of Patent: November 2, 2021
    Assignee: Roar Holding LLC
    Inventor: Robert W. Brocia
  • METHOD FOR ISOLATION OF MAO INHIBITORS FROM TEQUILA OR OTHER DISTILLED AGAVE FERMENTATION PRODUCTS
    Publication number: 20210069281
    Abstract: Improved compositions of reversible monoamine oxidase inhibitors are obtained by improved methods of alcohol removal from distillates of fermented agave extracts.
    Type: Application
    Filed: November 20, 2020
    Publication date: March 11, 2021
    Applicant: Roar Holding LLC
    Inventor: Robert W. BROCIA
  • Method for isolation of MAO inhibitors from tequila or other distilled agave fermentation products
    Patent number: 10842841
    Abstract: Improved compositions of reversible monoamine oxidase inhibitors are obtained by improved methods of alcohol removal from distillates of fermented agave extracts.
    Type: Grant
    Filed: April 5, 2018
    Date of Patent: November 24, 2020
    Assignee: Roar Holding LLC
    Inventor: Robert W. Brocia
  • METHODS TO IMPROVE BEVERAGE QUALITY
    Publication number: 20200165552
    Abstract: Agave derived beverages with improved quality contain enhanced ratios of MAO B to MAO A inhibitors or enhanced concentration of inhibitor of MAO B.
    Type: Application
    Filed: November 26, 2019
    Publication date: May 28, 2020
    Applicant: Roar Holding LLC
    Inventor: Robert W. BROCIA
  • DETERMINATION OF CHOLESTEROL ESTERASE
    Publication number: 20200103424
    Abstract: Advantage is taken of macrolide antibiotics' complexation with free cholesterol to yield fluorescent complexes to determine the levels of free cholesterol, total cholesterol, or lecithin: cholesterol acyl transferase (LCAT) in serum or plasma or fractions thereof or to determine the level of cholesterol esterase in a sample.
    Type: Application
    Filed: December 3, 2019
    Publication date: April 2, 2020
    Applicant: Roar Holding LLC
    Inventor: Robert W. BROCIA
  • Determination of LCAT
    Patent number: 10495652
    Abstract: Advantage is taken of macrolide antibiotics' complexation with free cholesterol to yield fluorescent complexes to determine the levels of free cholesterol, total cholesterol, or lecithin: cholesterol acyl transferase (LCAT) in serum or plasma or fractions thereof.
    Type: Grant
    Filed: March 12, 2015
    Date of Patent: December 3, 2019
    Assignee: Roar Holding LLC
    Inventor: Robert W. Brocia
  • ENERGY DRINKS AND OTHER NUTRITIONAL AIDS DERIVED FROM AGAVE-BASED SPIRITS
    Publication number: 20190231717
    Abstract: Compositions containing monoamine oxidase inhibitors prepared by removal of alcohol from agave-derived beverages are disclosed.
    Type: Application
    Filed: February 1, 2019
    Publication date: August 1, 2019
    Applicant: Roar Holding LLC
    Inventor: Robert W. BROCIA
  • Energy drinks and other nutritional aids derived from agave-based spirits
    Patent number: 10195163
    Abstract: Compositions containing monoamine oxidase inhibitors prepared by removal of alcohol from agave-derived beverages are disclosed.
    Type: Grant
    Filed: September 16, 2015
    Date of Patent: February 5, 2019
    Assignee: ROAR HOLDING LLC
    Inventor: Robert W. Brocia
  • METHOD FOR ISOLATION OF MAO INHIBITORS FROM TEQUILA OR OTHER DISTILLED AGAVE FERMENTATION PRODUCTS
    Publication number: 20180296629
    Abstract: Improved compositions of reversible monoamine oxidase inhibitors are obtained by improved methods of alcohol removal from distillates of fermented agave extracts.
    Type: Application
    Filed: April 5, 2018
    Publication date: October 18, 2018
    Applicant: Roar Holding LLC
    Inventor: Robert W. BROCIA
  • EX VIVO PLASMA ENZYME ACTIVITY ASSAY USING INHIBITORS AS A NEGATIVE CONTROL
    Publication number: 20180080941
    Abstract: An improved assay for enzyme activity in bodily fluids which permits the influence of other components of the fluid to be accounted for is improved by using a negative control where the enzyme is inactivated or bound.
    Type: Application
    Filed: November 28, 2017
    Publication date: March 22, 2018
    Applicant: ROAR HOLDING LLC
    Inventor: Robert W. BROCIA
  • ENERGY DRINKS AND OTHER NUTRITIONAL AIDS DERIVED FROM AGAVE-BASED SPIRITS
    Publication number: 20160074343
    Abstract: Compositions containing monoamine oxidase inhibitors prepared by removal of alcohol from agave-derived beverages are disclosed.
    Type: Application
    Filed: September 16, 2015
    Publication date: March 17, 2016
    Applicant: ROAR BIOMEDICAL, INC.
    Inventor: Robert W. BROCIA
  • Method to detect emphysema
    Patent number: 7851223
    Abstract: Methods to detect emphysema by assessing phospholipid transfer protein in lung lavage are described.
    Type: Grant
    Filed: February 26, 2005
    Date of Patent: December 14, 2010
    Assignee: Roar Holding LLC
    Inventor: Robert W. Brocia
  • Ex vivo method for determination of CETP activity and efficacy of heart disease treatment
    Patent number: 7642065
    Abstract: The present invention relates to a novel method to determine CETP activity in a bodily fluid sample wherein the sample may contain an inhibitor of CETP activity. The effect of the inhibitor is preserved to provide a more accurate determination of CETP activity in the fluid. Kits for the practice of the method are also provided.
    Type: Grant
    Filed: October 9, 2007
    Date of Patent: January 5, 2010
    Assignee: Roar Holding LLC
    Inventor: Robert W. Brocia
  • Assay for phospholipid transfer protein (PLTP) activity
    Patent number: 7618784
    Abstract: Improved methods for assaying the activity of phospholipid transfer protein (PLTP) enhance the signal-to-noise ratio by providing the substrate in donor particles with an aqueous core in the presence of suitable osmotic pressure.
    Type: Grant
    Filed: October 23, 2002
    Date of Patent: November 17, 2009
    Assignee: Roar Holding LLC
    Inventors: Robert W. Brocia, Xian-Cheng Jiang
  • High sensitivity fluorometric assays
    Patent number: 7553614
    Abstract: Spectrophotometric assays are rendered more sensitive by adding to the assay mixture a light-emitting moiety. The decrease in intensity of light emitted due to the presence of a light-absorbing moiety associated with the photometric assay is much more sensitive to analyte than the absorbance of the light-absorbing moiety itself.
    Type: Grant
    Filed: February 9, 2004
    Date of Patent: June 30, 2009
    Inventor: Robert W. Brocia
  • Ex vivo method for determination of CETP activity and efficacy of heart disease treatment
    Patent number: 7279297
    Abstract: The present invention relates to a novel method to determine CETP activity in a bodily fluid sample wherein the sample may contain an inhibitor of CETP activity. The effect of the inhibitor is preserved to provide a more accurate determination of CETP activity in the fluid. Kits for the practice of the method are also provided.
    Type: Grant
    Filed: April 11, 2003
    Date of Patent: October 9, 2007
    Assignee: Roar Holding LLC
    Inventor: Robert W. Brocia
  • Assay methods for transfer proteins that normalize for acceptor concentration
    Patent number: 6974676
    Abstract: A method to measure protein wherein said method internally controls for factors that affects protein activity such as substrate concentration.
    Type: Grant
    Filed: January 12, 1998
    Date of Patent: December 13, 2005
    Assignee: Roar Holding, LLC
    Inventor: Robert W Brocia